Identifying biomarkers that will help predict how individuals might be affected by their prostate cancer : A biopsy TMA analysis of biomarkers of prostate cancer behaviour

Institute of Cancer Research, SuttonDr Chris Parker£158,6352007 - 2010

Why we funded it

It is not currently possible to predict which cases of newly diagnosed prostate cancer will go on to cause symptoms, and immediate radical treatment for all cases is a standard approach. Biomarkers that accurately predict the course of individual cases would enable radical treatment to be given promptly to those men who need it, and the side effects of treatment to be avoided for those men who do not.

Scientific title

A biopsy TMA analysis of biomarkers of prostate cancer behaviour

Research project summary

Indicators, or 'biomarkers', of prostate cancer behaviour will be measured in biopsy samples from several hundred men with prostate cancer. To better understand which biomarkers can best predict how prostate cancer develops, the results will be analysed with respect to the rate of disease progression.